Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

被引:0
|
作者
Hizal, Mutlu [1 ]
Sendur, Mehmet A. N. [2 ]
Yalcin, Bulent [2 ]
机构
[1] Ankara City Hosp, Ankara, Turkey
[2] Yildirim Beyazit Univ, Ankara, Turkey
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 383卷 / 07期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:694 / 694
页数:1
相关论文
共 50 条
  • [31] Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
    Vithayathil, Mathew
    D'Alessio, Antonio
    Fulgenzi, Claudia A. M.
    Nishida, Naoshi
    Schoenlein, Martin
    von Felden, Johann
    Schulze, Kornelius
    Wege, Henning
    Saeed, Anwaar
    Wietharn, Brooke
    Hildebrand, Hannah
    Wu, Linda
    Ang, Celina
    Marron, Thomas U.
    Weinmann, Arndt
    Galle, Peter R.
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Lee, Pei-Chang
    Huang, Yi-Hsiang
    Amara, Suneetha
    Muzaffar, Mahvish
    Naqash, Abdul Rafeh
    Cammarota, Antonella
    Personeni, Nicola
    Pressiani, Tiziana
    Pinter, Matthias
    Cortellini, Alessio
    Kudo, Masatoshi
    Rimassa, Lorenza
    Pinato, David J.
    Sharma, Rohini
    LIVER INTERNATIONAL, 2022, 42 (11) : 2538 - 2547
  • [32] Duodenal Variceal Rupture during Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma
    Tsuruoka, Mio
    Inoue, Jun
    Ouchi, Keishi
    Uno, Kaname
    Itami, Hideaki
    Ninomiya, Masashi
    Iwata, Tomoaki
    Sano, Akitoshi
    Sato, Kosuke
    Onuki, Masazumi
    Sawahashi, Satoko
    Koike, Tomoyuki
    Masamune, Atsushi
    INTERNAL MEDICINE, 2023, 62 (10) : 1467 - 1472
  • [33] Cost-effectiveness of atezolizumab and bevacizumab in advanced hepatocellular carcinoma.
    Patel, Kishan
    Stein, Stacey
    Luther, Janki
    Huntington, Scott F.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports
    Ali AL Zahrani
    Ali Alfakeeh
    Journal of Medical Case Reports, 15
  • [35] New approval: Atezolizumab and bevacizumab for first line of unresecable hepatocellular carcinoma
    Minot-This, Marie-Sophie
    Edeline, Julien
    BULLETIN DU CANCER, 2021, 108 (02) : 139 - 140
  • [36] Letter to the editor: Atezolizumab plus bevacizumab for hepatocellular carcinoma in the real world
    Zhang, Junwei
    Fang, Jinyu
    Xun, Ziyu
    Xu, Yiyao
    Lu, Xin
    Zhao, Haitao
    HEPATOLOGY, 2022, 76 (04) : E84 - E85
  • [37] Treatment Outcomes and Toxicities for Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab
    Pakeerathan, Veenaa
    Babu, Hari
    Andelkovic, Vladimir
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 54 - 55
  • [38] Tumor microenvironment and clinical efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma
    Taira, Tomonao
    Kojima, Motohiro
    Yamaguchi, Shota
    Inoue, Kanae
    Eguchi, Hiroki
    Okumura, Kei
    Shibuki, Taro
    Satake, Tomoyuki
    Watanabe, Kazuo
    Sasaki, Mitsuhito
    Imaoka, Hiroshi
    Mitsunaga, Shuichi
    Ishii, Genichiro
    Ikeda, Masafumi
    ANNALS OF ONCOLOGY, 2023, 34 : S1399 - S1399
  • [39] Prediction for gastrointestinal bleeding in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
    Park, Kanghee
    Kim, Euichang
    Yang, Ji Won
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    JOURNAL OF HEPATOLOGY, 2023, 78 : S573 - S573
  • [40] Validation of the CRAFITY score in patients with hepatocellular carcinoma treated with atezolizumab and bevacizumab
    Scheiner, Bernhard
    Sartoris, Riccardo
    D'Alessio, Antonio
    Fulgenzi, Claudia
    Pomej, Katharina
    Balcar, Lorenz
    Bouattour, Mohamed
    Sidali, Sabrina
    Himmelsbach, Vera
    Finkelmeier, Fabian
    Schulze, Kornelius
    von Felden, Johann
    Hucke, Florian
    Shmanko, Kateryna
    Siebenhuner, Alexander
    Mertens, Joachim C.
    De Dosso, Sara
    Ebert, Matthias
    Teufel, Andreas
    Waldschmidt, Dirk-Thomas
    Radu, Iuliana Pompilia
    Krall, Anja
    Trauner, Michael
    Dufour, Jean-Francois
    Wege, Henning
    Weinmann, Arndt
    Trojan, Joerg
    Stauber, Rudolf E.
    Peck-Radosavljevic, Markus
    Hsu, Wei-Fan
    Vogel, Arndt
    Ronot, Maxime
    Pinato, David J.
    Pinter, Matthias
    JOURNAL OF HEPATOLOGY, 2023, 78 : S491 - S492